These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Tolerability of ziprasidone: an expanding perspective. Daniel DG J Clin Psychiatry; 2003; 64 Suppl 19():40-9. PubMed ID: 14728089 [TBL] [Abstract][Full Text] [Related]
12. Augmentation of clozapine with ziprasidone in refractory schizophrenia: a double-blind, placebo-controlled study. Muscatello MR; Pandolfo G; Micò U; Lamberti Castronuovo E; Abenavoli E; Scimeca G; Spina E; Zoccali R; Bruno A J Clin Psychopharmacol; 2014 Feb; 34(1):129-33. PubMed ID: 24145221 [TBL] [Abstract][Full Text] [Related]
13. Possible serotonin syndrome with citalopram following cross-titration of clozapine to ziprasidone. Kinzie E; Meltzer-Brody S Gen Hosp Psychiatry; 2005; 27(3):223-4. PubMed ID: 15882772 [No Abstract] [Full Text] [Related]
14. Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency. Chen HK; Chen CK; Tzeng NS Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1615-6. PubMed ID: 18597910 [No Abstract] [Full Text] [Related]
18. Tardive dystonia associated with ziprasidone. Papapetropoulos S; Wheeler S; Singer C Am J Psychiatry; 2005 Nov; 162(11):2191. PubMed ID: 16263868 [No Abstract] [Full Text] [Related]
19. Ziprasidone versus clozapine in the treatment of dually diagnosed (DD) patients with schizophrenia and cannabis use disorders: a randomized study. Schnell T; Koethe D; Krasnianski A; Gairing S; Schnell K; Daumann J; Gouzoulis-Mayfrank E Am J Addict; 2014; 23(3):308-12. PubMed ID: 24628830 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial. Zink M; Kuwilsky A; Krumm B; Dressing H J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]